|
|
|
|
LEADER |
00000cam a22000008a 4500 |
001 |
8846609 |
003 |
ICU |
005 |
20131022150400.0 |
008 |
110822s2012 enk b 001 0 eng |
010 |
|
|
|a 2011035406
|
016 |
7 |
|
|a 101567442
|2 DNLM
|
019 |
|
|
|a 769419532
|
020 |
|
|
|a 9781906799083 (v. 1)
|
020 |
|
|
|a 1906799083 (v. 1)
|
020 |
|
|
|a 9781906799182 (v. 2)
|
020 |
|
|
|a 1906799180 (v. 2)
|
035 |
|
|
|a 8846609
|
035 |
|
|
|a (OCoLC)747903378
|z (OCoLC)769419532
|
040 |
|
|
|a DNLM/DLC
|b eng
|c DLC
|d NLM
|d CDX
|d YDXCP
|d BTCTA
|d CUI
|d UBY
|d UtOrBLW
|
042 |
|
|
|a pcc
|
049 |
|
|
|a CGUA
|
050 |
|
4 |
|a RS189
|b .C68 2012
|
060 |
0 |
0 |
|a 2012 D-694
|
060 |
1 |
0 |
|a QV 773 C855 2012
|
082 |
0 |
0 |
|a 338.4/76153
|2 23
|
245 |
0 |
0 |
|a Counterfeit medicines /
|c edited by Albert I. Wertheimer and Perry G. Wang.
|
260 |
|
|
|a Porters Wood, St. Albans, Hertfordshire, UK :
|b ILM Publications,
|c 2012.
|
263 |
|
|
|a 1112
|
300 |
|
|
|a v. :
|b ill. ;
|c 24 cm
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a V. 1. Policy, economics, and countermeasures -- v. 2. Identification and analysis.
|
505 |
0 |
|
|a The background and history of counterfeit medicines / Obinna Obi-Eyisi and Albert I. Wertheimer -- The current policy and law of counterfeit medicines : in memoriam to Donald Eulette deKieffer, 1945-2011 / Donald deKieffer and J. Kevin Horgan -- The financial and economic aspects of counterfeit medicines / F. Ellen Loh -- The counterfeiting of pharmaceutical products in lesser developed countries : a case study of Mexico / Rafael Gual Cosio -- The fight against counterfeit and substandard pharmaceuticals by governments, international agencies, and professional societies / Anna Gu -- International politics becomes involved in the fight against counterfeit medicines / Kawthar ElBishlawi -- Addressing illicit online pharmacies : global patient safety and regulatory challenges / Bryan A. Liang and Tim MacKey -- Counterfeiting in other industries : lessons for pharmaceuticals / Nazli Sencan -- Overview of the selection of strategic authentication and tracing programmes / John Spink.
|
520 |
3 |
|
|a "Discusses the economic and financial consequences of pharmaceutical product counterfeiting and describes some of the measures that can be taken to counteract their impact"--Provided by publisher.
|
650 |
|
0 |
|a Product counterfeiting
|v Case studies.
|
650 |
|
0 |
|a Counterfeits and counterfeiting
|x Prevention.
|
650 |
|
0 |
|a Drug adulteration.
|0 http://id.loc.gov/authorities/subjects/sh85039693
|
650 |
|
0 |
|a Drugs
|x Law and legislation.
|0 http://id.loc.gov/authorities/subjects/sh85039735
|
650 |
|
7 |
|a Counterfeits and counterfeiting
|x Prevention.
|2 fast
|0 http://id.worldcat.org/fast/fst00881323
|
650 |
|
7 |
|a Drug adulteration.
|2 fast
|0 http://id.worldcat.org/fast/fst00898652
|
650 |
|
7 |
|a Drugs
|x Law and legislation.
|2 fast
|0 http://id.worldcat.org/fast/fst00898830
|
650 |
|
7 |
|a Product counterfeiting.
|2 fast
|0 http://id.worldcat.org/fast/fst01078205
|
655 |
|
7 |
|a Case studies.
|2 fast
|0 http://id.worldcat.org/fast/fst01423765
|
700 |
1 |
|
|a Wertheimer, Albert I.
|0 http://id.loc.gov/authorities/names/n80118348
|1 http://viaf.org/viaf/25911769
|
700 |
1 |
|
|a Wang, Perry G.
|0 http://id.loc.gov/authorities/names/n2008180372
|1 http://viaf.org/viaf/44636744
|
903 |
|
|
|a HeVa
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i 36fe58f8-17a2-5dd0-892c-4ecc685a5e27
|s 5ddeecb9-61ce-54c1-9c44-df7ea147160a
|
928 |
|
|
|t Library of Congress classification
|a RS189 .C68 2012
|l JCL
|c JCL-Sci
|i 700019
|
927 |
|
|
|t Library of Congress classification
|a RS189 .C68 2012
|v v.1
|l JCL
|c JCL-Sci
|e CRERAR
|b 106977476
|i 9065124
|